Related Experiment Video
Updated: Nov 27, 2025
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Chronic Diseases and COVID-19: A Review
Mohammed Ajebli1, Ayoub Amssayef1, Mourad Akdad1
1Department of Ethnopharmacology and Pharmacognosy, Faculty of Sciences and Techniques Errachidia, Moulay Ismail University of Meknes, BP 509, Boutalamine, Errachidia, 52000, Morocco.
Patients with chronic diseases face higher COVID-19 mortality due to immune system impacts and organ damage. This review explores preventive strategies, including diet and supplements, to mitigate risks for vulnerable populations.
Area of Science:
- Immunology
- Infectious Diseases
- Public Health
Background:
- COVID-19 infection exacerbates immune deficiencies common in chronic diseases.
- The novel coronavirus targets vital organs like lungs, heart, kidneys, and brain.
- This leads to increased vulnerability and comorbidity in patients with pre-existing conditions.
Purpose of the Study:
- To review preventive recommendations for COVID-19 patients with chronic diseases.
- To explore pharmacological, dietary, and natural approaches to avoid fatal complications.
- To identify strategies for limiting comorbidity risks in this vulnerable group.
Main Methods:
- Bibliographic research was conducted to gather information.
- The review synthesized data on interactions between medications, diet, and COVID-19.
- It considered the role of nutrients and bioactive compounds in immune response and disease management.
Main Results:
- Certain medications may interact negatively with COVID-19 in patients with diabetes or hypertension.
- Nutrient-rich foods (vitamins, minerals, antioxidants) can improve immune response and manage chronic conditions.
- Vitamins, minerals, antioxidants, prebiotics, and probiotics show potential benefits.
Conclusions:
- COVID-19 patients with chronic diseases require specific preventive strategies.
- Dietary and supplemental interventions may play a crucial role in managing comorbidity.
- Further epidemiological, clinical, and experimental research is needed to elucidate causal mechanisms and optimize solutions.
More Related Videos
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...